Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Cantor Fitzgerald
Johnson and Johnson
US Department of Justice
Queensland Health

Generated: September 23, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Summary for Patent: ► Subscribe

Title: Dibenz[b,e]oxepin derivative and pharmaceutical compositions thereof
Abstract:Novel dibenz[b,e]oxepin derivatives are employed in the treatment and control of allergic conditions such as allergic asthma and also employed in the treatment of inflammation.
Inventor(s): Oshima; Etsuo (Shizuoka, JP), Kumazawa; Toshiaki (Shizuoka, JP), Otaki; Shizuo (Shizuoka, JP), Obase; Hiroyuki (Shizuoka, JP), Ohmori; Kenji (Mishima, JP), Ishii; Hidee (Shizuoka, JP), Manabe; Haruhiko (Shizuoka, JP), Tamura; Tadafumi (Shizuoka, JP), Shuto; Katsuichi (Shizuoka, JP)
Assignee: Kyowa Hakko Kogyo Co., Ltd. (Tokyo, JP)
Application Number:07/020,900
Patent Claim Types:
see list of patent claims
Compound; Composition;

No matches for this query

Foreign Priority and PCT Information for Patent: ► Subscribe

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan61-45676Mar 03, 1986

International Patent Family for Patent: ► Subscribe

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada1337603► Subscribe
Germany3778734► Subscribe
European Patent Office0235796► Subscribe
Spain2038608► Subscribe
Hong Kong68996► Subscribe
JapanH0586925► Subscribe
JapanS6310784► Subscribe
Mexico9203155► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Fish and Richardson
Express Scripts
Queensland Health
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus